Clinical Trials Logo

Keratoconus clinical trials

View clinical trials related to Keratoconus.

Filter by:

NCT ID: NCT02875145 Completed - Cataract Clinical Trials

Impact of Cataract Surgery on Keratoplasty Graft Survival

IGREC
Start date: August 2014
Phase: N/A
Study type: Observational

The follow up time after keratoplasty now routinely exceeds multiple decades. It is common for keratoplasty patients to also undergo cataract surgery at a later date in their lives. Keratoplasties and cataract surgery both result in local inflammation. This may influence the density of endothelial cells, and on average there is a loss of 10% in endothelial cells within 3 months of the cataract surgery. Yet, a sufficient density of endothelial cells is required to maintain graft transparency. It may be therefore difficult to strike a balance between loss of visual acuity due to the cataract of to the loss of graft transparency over the long term. The investigators aim to compare graft survival in patients with clear crystalline lens with and without cataract surgery.

NCT ID: NCT02867176 Completed - Pain Clinical Trials

Pain Management in Corneal Collagen Crosslinking for Keratoconus

Start date: January 2016
Phase: Phase 4
Study type: Interventional

This is a prospective, randomized, single blind study. Patients enrolled in the study were randomly assigned to a ketorolac or a gabapentin group for pain control. Different pain scores and variables will be evaluated, along with others side effects variables.

NCT ID: NCT02861339 Completed - Clinical trials for Inflammatory Bowel Diseases

Prevalence of Keratoconus in Inflammatory Bowel Diseases

OSCAR
Start date: February 2014
Phase: N/A
Study type: Interventional

A retrospective study has shown the association between the inflammatory bowel diseases (IBD) and the presence of a keratoconus. This new study will measure the prevalence of keratoconus and follow its activity in patients affected by IBD and followed up in hepatology-gastroenterology department at Nancy Hospital. The prevalence of keratoconus will be compared to known data of literature about general population. The secondary purpose is to search for a relationship between the presence of a keratoconus and activity criteria of IBD. Perspectives are a systematic screening for keratoconus in patients affected by IBD with the amelioration of the ophthalmologic care of IBD patients and confirmation of the recent hypothesis of inflammatory origin of keratoconus.

NCT ID: NCT02849808 Completed - Keratoconus Clinical Trials

Long Term Cornea Graft Survival Study

BELIEvE
Start date: January 15, 2015
Phase: N/A
Study type: Observational [Patient Registry]

Corneal transplantation have been performed for several decades, follow-up time in some centers now exceeds 30 years. Published long term (10 years and up) graft survivals vary considerably from center to center. These variations may be explained by differences in case-mix and surgical techniques used. The investigators aim to better understand the factors associated with long term graft survival.

NCT ID: NCT02834260 Completed - Keratoconus Clinical Trials

Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study

IDEXACOR
Start date: January 10, 2017
Phase: Phase 2
Study type: Interventional

Immune rejection episodes after penetrating keratoplasty occur in 30% of patients and constitute one of the main factors reducing graft survival. They mainly occur during the first 18 months. Prevention usually relies on a topical treatment with dexamethasone or prednisolone for standard risk patients. Eye drops are instilled three times a day during at least 3 months then tapered. OZURDEX is an absorbable small implant that releases a total of 700 micrograms dexamethasone during several months. It is indicated for intravitreal injection to treat macular edema. The investigators hypothesized that this implant could be used after subconjunctival injection during corneal graft, to prevent immune rejection and avoid repeated eyedrop instillations.

NCT ID: NCT02812563 Completed - Keratoconus Clinical Trials

Familial Analysis of Keratoconus Risk

AFRIK
Start date: November 25, 2014
Phase: N/A
Study type: Observational

The principal objective of this study is to evaluate the frequency of KC inside family of patients with confirmed KC. It's a familial, epidemiological, prospective, single-center study.

NCT ID: NCT02806921 Completed - Keratoconus Clinical Trials

Changes in the Tear Film With Scleral Contact Lens Wear for Keratoconic Eyes

Start date: August 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate changes in the level of inflammatory mediators in the tear film of scleral contact lens wearers in a keratoconic population.

NCT ID: NCT02698709 Completed - Keratoconus Clinical Trials

Astigmatic Vector Analysis of Posterior Cornea - a Comparison Among Healthy, Forme Fruste and Overt Keratoconus Corneas

Start date: May 2015
Phase: N/A
Study type: Observational

The main purpose of this study is to determine new diagnostic criteria for an eye disease called keratoconus.

NCT ID: NCT02625467 Completed - Keratoconus Clinical Trials

Treatment of Keratoconus With PALK Versus PK

Start date: June 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the visual results of patients with keratoconus treated with one of two techniques: penetrating keratoplasty (PK) vs. pachymetry and Excimer laser assisted lamellar keratoplasty (PALK).

NCT ID: NCT02617368 Completed - Keratoconus Clinical Trials

Fourier Transform of Videokeratography Data: Clinical Usefulness in Moderate and Frome Fruste Keratoconus

FFTKC
Start date: November 2014
Phase: N/A
Study type: Observational

Primary objective of this study was evaluate the diagnostic capacity of fourier analysis of keratometric data in differentiating moderate KC and FFK from healthy corneas. Study participants were recruited from the Cornea Outpatient service in a consecutive if eligible basis. Two study groups were formed: a)KC group included patients those were diagnosed and classified for moderate keratoconus according to the Amsler-Krumeich classification system, b) FFK group (FFKG) that included patients diagnosed with FFK, and c) Control group (CG) was formed by refractive surgery candidates. Pentacam (Pentacam HR, Oculus Optikgerate GmbH, Heidelberg, Germany)measurements were performed by the same experienced operator in a consistent way.